Catabasis Story

<div class='circular--portrait' style='background:#FF01C9;color: #FFF8DC;font-size:4em;'>CP</div>
CATB -- USA Stock  

USD 6.94  0.17  2.51%

Given the investment horizon of 60 days, Catabasis Pharmaceuticals is expected to generate 2.49 times more return on investment than the market. However, the company is 2.49 times more volatile than its market benchmark. It trades about 0.11 of its potential returns per unit of risk. The DOW is currently generating roughly 0.13 per unit of risk. As many investors are getting excited about healthcare space, it is fair to go over Catabasis Pharmaceuticals. We will evaluate if the latest Catabasis Pharmaceuticals price volatility suggests a bounce in September.
Published over three weeks ago
View all stories for Catabasis Pharmaceuticals | View All Stories
Will Catabasis Pharmaceuticals (NASDAQ:CATB) current volatility force investors to sell?
This firm conducts business under Healthcare sector and is part of Biotechnology industry.
Volatility is a rate at which the price of Catabasis Pharmaceuticals or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Catabasis Pharmaceuticals may increase or decrease. In other words, similar to Catabasis's beta indicator, it measures the risk of Catabasis Pharmaceuticals and helps estimate the fluctuations that may happen in a short period of time. So if prices of Catabasis Pharmaceuticals fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility. Please read more on our technical analysis page.

How important is Catabasis Pharmaceuticals's Liquidity

Catabasis Pharmaceuticals financial leverage refers to using borrowed capital as a funding source to finance Catabasis Pharmaceuticals ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. Catabasis Pharmaceuticals financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between Catabasis Pharmaceuticals's total debt and its cash.

How Catabasis utilizes its cash?

To perform a cash flow analysis of Catabasis Pharmaceuticals, investors first need to understand how to read the cash flow statement. A cash flow statement shows the amount of cash Catabasis Pharmaceuticals is receiving and how much cash it distributes out in a given period. The Catabasis Pharmaceuticals cash flow statement breaks down these inflows and outflows into different buckets, including operating activities, investing activities, and financing activities. Catabasis Pharmaceuticals Net Cash Flow from Operations is projected to decrease significantly based on the last few years of reporting. The past year's Net Cash Flow from Operations was at (26.57 Million)

Catabasis Pharmaceuticals Volatility Drivers

Catabasis Pharmaceuticals unsystematic risk is unique to Catabasis Pharmaceuticals and usually not directly affected by the market or economic environment. An example of unsystematic risk is the possibility of poor earnings or a layoff due to coronavirus. One may mitigate nonsystematic risk by buying different securities in the same industry or by buying in different sectors. For example, if you have a position in Catabasis Pharmaceuticals you can also buy Precision BioSciences. You can also mitigate this risk by investing in the biotechnology sector as well as in companies having nothing to do with it. This type of risk is also called diversifiable risk and can be understood from analyzing Catabasis Pharmaceuticals important indicators over time. Here we run a correlation analysis between relevant fundamental ratios over at least ten year period to find a relationship in the way they react to changes in Catabasis Pharmaceuticals income statement and balance sheet. Here are more details about Catabasis volatility.
1.00.550.480.550.690.1-0.220.51-0.54-0.270.48-0.54-0.540.53-0.540.3-0.260.33-0.270.570.310.270.220.510.52-0.270.22-0.33-0.24-0.270.86-0.440.22-0.270.87-0.540.540.14-0.50.40.430.011.00.99
1.00.590.510.540.670.06-0.190.51-0.53-0.210.5-0.53-0.530.52-0.530.25-0.270.32-0.210.550.330.240.170.490.5-0.210.17-0.32-0.2-0.210.83-0.440.17-0.220.86-0.530.510.14-0.490.360.390.031.00.99
0.550.590.90.2-0.01-0.640.340.17-0.060.490.66-0.06-0.06-0.020.01-0.57-0.52-0.210.49-0.090.37-0.25-0.42-0.18-0.170.49-0.420.320.030.490.11-0.04-0.420.490.25-0.06-0.220.430.04-0.54-0.450.590.550.6
0.480.510.90.26-0.07-0.750.210.32-0.20.460.75-0.2-0.20.11-0.13-0.58-0.78-0.140.46-0.160.13-0.14-0.46-0.22-0.220.46-0.460.38-0.10.460.110.01-0.460.440.29-0.2-0.220.58-0.1-0.46-0.320.660.480.5
0.550.540.20.260.840.25-0.680.97-0.96-0.130.78-0.96-0.960.95-0.940.25-0.470.88-0.130.86-0.530.80.060.840.83-0.130.060.050.14-0.130.51-0.930.06-0.140.79-0.960.81-0.34-0.950.340.41-0.50.550.43
0.690.67-0.01-0.070.840.62-0.740.77-0.85-0.460.39-0.85-0.850.88-0.870.64-0.020.87-0.460.98-0.260.790.380.980.98-0.460.38-0.40.06-0.460.79-0.890.38-0.460.88-0.850.97-0.49-0.870.70.66-0.680.690.59
0.10.06-0.64-0.750.250.62-0.60.18-0.29-0.8-0.4-0.29-0.290.38-0.360.920.510.54-0.80.65-0.240.560.690.690.69-0.80.69-0.45-0.16-0.80.48-0.480.69-0.80.36-0.290.71-0.56-0.410.80.7-0.760.10.03
-0.22-0.190.340.21-0.68-0.74-0.6-0.730.790.38-0.250.790.79-0.820.81-0.550.08-0.90.38-0.750.74-0.98-0.33-0.81-0.790.38-0.330.32-0.130.38-0.550.77-0.330.38-0.640.79-0.820.530.83-0.64-0.540.69-0.22-0.08
0.510.510.170.320.970.770.18-0.73-0.98-0.150.78-0.98-0.980.96-0.960.24-0.590.86-0.150.78-0.620.830.080.770.76-0.150.080.070.04-0.150.53-0.850.08-0.160.8-0.980.77-0.21-0.970.370.45-0.410.510.38
-0.54-0.53-0.06-0.2-0.96-0.85-0.290.79-0.980.21-0.691.01.0-0.991.0-0.350.44-0.920.21-0.850.57-0.87-0.14-0.85-0.850.21-0.140.13-0.10.21-0.610.88-0.140.22-0.841.0-0.860.330.99-0.5-0.550.54-0.54-0.41
-0.27-0.210.490.46-0.13-0.46-0.80.38-0.150.210.380.210.21-0.30.28-0.94-0.16-0.271.0-0.420.07-0.33-0.84-0.45-0.451.0-0.840.280.71.0-0.60.18-0.841.0-0.450.21-0.53-0.020.35-0.83-0.870.31-0.27-0.2
0.480.50.660.750.780.39-0.4-0.250.78-0.690.38-0.69-0.690.62-0.63-0.36-0.780.460.380.39-0.330.39-0.330.340.340.38-0.320.380.210.380.2-0.58-0.330.380.53-0.690.30.08-0.61-0.23-0.090.060.480.41
-0.54-0.53-0.06-0.2-0.96-0.85-0.290.79-0.981.00.21-0.691.0-0.991.0-0.350.44-0.920.21-0.850.57-0.87-0.14-0.85-0.850.21-0.140.13-0.10.21-0.610.88-0.140.22-0.841.0-0.860.330.99-0.5-0.550.54-0.54-0.41
-0.54-0.53-0.06-0.2-0.96-0.85-0.290.79-0.981.00.21-0.691.0-0.991.0-0.350.44-0.920.21-0.850.57-0.87-0.14-0.85-0.850.21-0.140.13-0.10.21-0.610.88-0.140.22-0.841.0-0.860.330.99-0.5-0.550.54-0.54-0.41
0.530.52-0.020.110.950.880.38-0.820.96-0.99-0.30.62-0.99-0.99-1.00.44-0.370.94-0.30.88-0.580.890.20.890.88-0.30.2-0.170.07-0.30.63-0.880.2-0.30.84-0.990.9-0.37-0.990.580.61-0.590.530.4
-0.54-0.530.01-0.13-0.94-0.87-0.360.81-0.961.00.28-0.631.01.0-1.0-0.420.38-0.940.28-0.880.57-0.88-0.2-0.88-0.870.28-0.20.18-0.080.28-0.640.87-0.20.29-0.851.0-0.890.350.99-0.57-0.610.58-0.54-0.41
0.30.25-0.57-0.580.250.640.92-0.550.24-0.35-0.94-0.36-0.35-0.350.44-0.420.330.48-0.940.61-0.130.50.780.650.65-0.940.78-0.5-0.44-0.940.67-0.370.78-0.940.52-0.350.71-0.28-0.470.940.89-0.580.30.23
-0.26-0.27-0.52-0.78-0.47-0.020.510.08-0.590.44-0.16-0.780.440.44-0.370.380.33-0.13-0.160.00.36-0.170.140.030.04-0.160.14-0.630.3-0.16-0.080.160.14-0.16-0.340.440.02-0.570.410.250.0-0.44-0.26-0.19
0.330.32-0.21-0.140.880.870.54-0.90.86-0.92-0.270.46-0.92-0.920.94-0.940.48-0.13-0.270.91-0.660.960.210.940.93-0.270.21-0.250.27-0.270.52-0.930.21-0.270.7-0.920.92-0.63-0.930.580.53-0.80.330.2
-0.27-0.210.490.46-0.13-0.46-0.80.38-0.150.211.00.380.210.21-0.30.28-0.94-0.16-0.27-0.420.07-0.33-0.84-0.45-0.451.0-0.840.280.71.0-0.60.18-0.841.0-0.450.21-0.53-0.020.35-0.83-0.870.31-0.27-0.2
0.570.55-0.09-0.160.860.980.65-0.750.78-0.85-0.420.39-0.85-0.850.88-0.880.610.00.91-0.42-0.350.820.360.991.0-0.420.36-0.340.14-0.420.68-0.940.36-0.420.8-0.850.98-0.59-0.870.660.62-0.770.570.47
0.310.330.370.13-0.53-0.26-0.240.74-0.620.570.07-0.330.570.57-0.580.57-0.130.36-0.660.07-0.35-0.76-0.03-0.41-0.390.07-0.03-0.29-0.150.070.060.53-0.030.08-0.160.57-0.40.350.62-0.15-0.180.450.310.45
0.270.24-0.25-0.140.80.790.56-0.980.83-0.87-0.330.39-0.87-0.870.89-0.880.5-0.170.96-0.330.82-0.760.280.860.85-0.330.28-0.210.17-0.330.53-0.870.28-0.330.68-0.870.87-0.55-0.90.580.52-0.710.270.13
0.220.17-0.42-0.460.060.380.69-0.330.08-0.14-0.84-0.33-0.14-0.140.2-0.20.780.140.21-0.840.36-0.030.280.390.39-0.841.0-0.23-0.55-0.840.54-0.151.0-0.790.37-0.140.440.08-0.260.690.72-0.250.220.17
0.510.49-0.18-0.220.840.980.69-0.810.77-0.85-0.450.34-0.85-0.850.89-0.880.650.030.94-0.450.99-0.410.860.391.0-0.450.39-0.360.14-0.450.68-0.930.39-0.450.79-0.850.99-0.61-0.880.70.65-0.810.510.4
0.520.5-0.17-0.220.830.980.69-0.790.76-0.85-0.450.34-0.85-0.850.88-0.870.650.040.93-0.451.0-0.390.850.391.0-0.450.39-0.360.14-0.450.67-0.930.39-0.450.78-0.850.99-0.61-0.880.70.65-0.810.520.41
-0.27-0.210.490.46-0.13-0.46-0.80.38-0.150.211.00.380.210.21-0.30.28-0.94-0.16-0.271.0-0.420.07-0.33-0.84-0.45-0.45-0.840.280.71.0-0.60.18-0.841.0-0.450.21-0.53-0.020.35-0.83-0.870.31-0.27-0.2
0.220.17-0.42-0.460.060.380.69-0.330.08-0.14-0.84-0.32-0.14-0.140.2-0.20.780.140.21-0.840.36-0.030.281.00.390.39-0.84-0.23-0.55-0.840.54-0.151.0-0.790.37-0.140.440.08-0.260.690.72-0.250.220.17
-0.33-0.320.320.380.05-0.4-0.450.320.070.130.280.380.130.13-0.170.18-0.5-0.63-0.250.28-0.34-0.29-0.21-0.23-0.36-0.360.28-0.23-0.190.28-0.560.09-0.230.28-0.310.13-0.410.420.1-0.66-0.420.44-0.33-0.36
-0.24-0.20.03-0.10.140.06-0.16-0.130.04-0.10.70.21-0.1-0.10.07-0.08-0.440.30.270.70.14-0.150.17-0.550.140.140.7-0.55-0.190.7-0.34-0.29-0.550.71-0.22-0.10.05-0.70.0-0.32-0.51-0.43-0.24-0.22
-0.27-0.210.490.46-0.13-0.46-0.80.38-0.150.211.00.380.210.21-0.30.28-0.94-0.16-0.271.0-0.420.07-0.33-0.84-0.45-0.451.0-0.840.280.7-0.60.18-0.841.0-0.450.21-0.53-0.020.35-0.83-0.870.31-0.27-0.2
0.860.830.110.110.510.790.48-0.550.53-0.61-0.60.2-0.61-0.610.63-0.640.67-0.080.52-0.60.680.060.530.540.680.67-0.60.54-0.56-0.34-0.6-0.490.54-0.590.92-0.610.74-0.02-0.630.770.73-0.250.860.81
-0.44-0.44-0.040.01-0.93-0.89-0.480.77-0.850.880.18-0.580.880.88-0.880.87-0.370.16-0.930.18-0.940.53-0.87-0.15-0.93-0.930.18-0.150.09-0.290.18-0.49-0.150.18-0.710.88-0.880.60.88-0.4-0.370.71-0.44-0.33
0.220.17-0.42-0.460.060.380.69-0.330.08-0.14-0.84-0.33-0.14-0.140.2-0.20.780.140.21-0.840.36-0.030.281.00.390.39-0.841.0-0.23-0.55-0.840.54-0.15-0.790.37-0.140.440.08-0.260.690.72-0.250.220.17
-0.27-0.220.490.44-0.14-0.46-0.80.38-0.160.221.00.380.220.22-0.30.29-0.94-0.16-0.271.0-0.420.08-0.33-0.79-0.45-0.451.0-0.790.280.711.0-0.590.18-0.79-0.450.22-0.53-0.010.36-0.83-0.870.31-0.27-0.21
0.870.860.250.290.790.880.36-0.640.8-0.84-0.450.53-0.84-0.840.84-0.850.52-0.340.7-0.450.8-0.160.680.370.790.78-0.450.37-0.31-0.22-0.450.92-0.710.37-0.45-0.840.82-0.07-0.840.630.66-0.30.870.79
-0.54-0.53-0.06-0.2-0.96-0.85-0.290.79-0.981.00.21-0.691.01.0-0.991.0-0.350.44-0.920.21-0.850.57-0.87-0.14-0.85-0.850.21-0.140.13-0.10.21-0.610.88-0.140.22-0.84-0.860.330.99-0.5-0.550.54-0.54-0.41
0.540.51-0.22-0.220.810.970.71-0.820.77-0.86-0.530.3-0.86-0.860.9-0.890.710.020.92-0.530.98-0.40.870.440.990.99-0.530.44-0.410.05-0.530.74-0.880.44-0.530.82-0.86-0.55-0.890.780.73-0.780.540.43
0.140.140.430.58-0.34-0.49-0.560.53-0.210.33-0.020.080.330.33-0.370.35-0.28-0.57-0.63-0.02-0.590.35-0.550.08-0.61-0.61-0.020.080.42-0.7-0.02-0.020.60.08-0.01-0.070.33-0.550.33-0.29-0.070.90.140.18
-0.5-0.490.04-0.1-0.95-0.87-0.410.83-0.970.990.35-0.610.990.99-0.990.99-0.470.41-0.930.35-0.870.62-0.9-0.26-0.88-0.880.35-0.260.10.00.35-0.630.88-0.260.36-0.840.99-0.890.33-0.57-0.630.57-0.5-0.36
0.40.36-0.54-0.460.340.70.8-0.640.37-0.5-0.83-0.23-0.5-0.50.58-0.570.940.250.58-0.830.66-0.150.580.690.70.7-0.830.69-0.66-0.32-0.830.77-0.40.69-0.830.63-0.50.78-0.29-0.570.94-0.60.40.32
0.430.39-0.45-0.320.410.660.7-0.540.45-0.55-0.87-0.09-0.55-0.550.61-0.610.890.00.53-0.870.62-0.180.520.720.650.65-0.870.72-0.42-0.51-0.870.73-0.370.72-0.870.66-0.550.73-0.07-0.630.94-0.460.430.34
0.010.030.590.66-0.5-0.68-0.760.69-0.410.540.310.060.540.54-0.590.58-0.58-0.44-0.80.31-0.770.45-0.71-0.25-0.81-0.810.31-0.250.44-0.430.31-0.250.71-0.250.31-0.30.54-0.780.90.57-0.6-0.460.010.1
1.01.00.550.480.550.690.1-0.220.51-0.54-0.270.48-0.54-0.540.53-0.540.3-0.260.33-0.270.570.310.270.220.510.52-0.270.22-0.33-0.24-0.270.86-0.440.22-0.270.87-0.540.540.14-0.50.40.430.010.99
0.990.990.60.50.430.590.03-0.080.38-0.41-0.20.41-0.41-0.410.4-0.410.23-0.190.2-0.20.470.450.130.170.40.41-0.20.17-0.36-0.22-0.20.81-0.330.17-0.210.79-0.410.430.18-0.360.320.340.10.99
Click cells to compare fundamentals   

Acquisition by Joanne Beck of 7500 shares of Catabasis Pharmaceuticals subject to Rule 16b-3

Legal trades by Catabasis Pharmaceuticals insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Catabasis insider trading alert for grant of stock option (right to buy) by Joanne Beck, the corporate stakeholder, on 12th of June 2020. This event was filed by Catabasis Pharmaceuticals with SEC on 2020-06-12. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

Breaking down Catabasis Pharmaceuticals Further

The company reported the previous year's revenue of 250 K. Net Loss for the year was (30.58 M) with profit before overhead, payroll, taxes, and interest of 500 K.

Over 3 percent rise for Catabasis Pharmaceuticals. What does it mean for investors?

Catabasis Pharmaceuticals information ratio is up to 0.0. Catabasis Pharmaceuticals shows above-average downside volatility for the selected time horizon. We advise investors to inspect Catabasis Pharmaceuticals further and ensure that all market timing and asset allocation strategies are consistent with the estimation of Catabasis Pharmaceuticals future alpha.

Our Final Take On Catabasis Pharmaceuticals

Whereas some other firms within the biotechnology industry are still a little expensive, even after the recent corrections, Catabasis Pharmaceuticals may offer a potential longer-term growth to investors. The inconsistency in the assessment between current Catabasis valuation and our trade advice on Catabasis Pharmaceuticals is due to the recent market swings and y